Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2012
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2489526C Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
03/20/2012CA2462227C Adhesive antineoplastic compositions
03/20/2012CA2453510C Treatment of fatigue and cognitive side effects associated with cancer, cancer treatments and menopause with d-threo-methyphenidate
03/20/2012CA2444463C Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/20/2012CA2441292C Equine herpesvirus vaccine
03/20/2012CA2424359C Implants with a phosphazene-containing coating
03/20/2012CA2406206C Improvements in or relating to formulations for use in inhaler devices
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/15/2012WO2012033941A1 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012WO2012033189A1 Agent for treatment of dry eye characterized by combining p2y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
03/15/2012WO2012033162A1 Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
03/15/2012WO2012033016A1 Drug for treating tumor, antitumor agent, method for treating tumor and kit for treating tumor
03/15/2012WO2012032360A2 Novel use
03/15/2012WO2012031978A1 Laxative containing polyethylene glycol and electrolytes
03/15/2012WO2012016000A3 Preservative free brimonidine and timolol solutions
03/15/2012WO2002033044A9 Methods of high-throughput screening for internalizing antibodies
03/15/2012US20120065358 Biodegradable poly(beta-amino esters) and uses thereof
03/15/2012US20120065145 Alkylating agent combinations in the treatment of cancer
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064160 Fibrate-statin Combinations with Reduced Fed-fasted Effects
03/15/2012US20120064156 Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs
03/15/2012US20120064154 Solid drug for oral use
03/15/2012US20120064129 Gastric retained gabapentin dosage form
03/15/2012US20120064056 Dichloracetate in combination with clinically high levels of cardioprotective or hemodynamic drugs
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody
03/15/2012CA2812034A1 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012CA2810481A1 Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
03/15/2012CA2809203A1 Novel use
03/14/2012EP2428207A1 Alpha-2B adrenergic receptor agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain
03/14/2012EP2427193A1 Use of pde7 inhibitors for the treatment of movement disorders
03/14/2012EP2427181A2 Topical compositions comprising an alkoxylated diphenylacrylate compound and an aryl carboxylic ester
03/14/2012EP2187741B1 Novel forms of cddo methyl ester
03/14/2012EP2086538B1 Combination therapies for treating alzheimer's disease using dimebon and donepezil
03/14/2012EP2049112B1 Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents
03/14/2012EP1707215B1 Remedy for vasculitis
03/14/2012EP1519743B1 Use of an interleukin 1 receptor antagonist alone or in combination with pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1471895B2 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
03/14/2012EP1332218B1 Differentiation-inducing substances
03/14/2012CN102378633A Immunologic adjuvant composition and use thereof
03/14/2012CN102378627A Antibacterial composition comprising 4 -isopropyl-3-methylpheno and zinc ions
03/14/2012CN102372773A Human bladder cancer tumor marker, antibody thereof and application thereof
03/14/2012CN102372764A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus
03/14/2012CN102370987A Injection liposome entrapping antineoplastic pharmaceutical composition
03/14/2012CN102370986A Pharmaceutical compositions containing hydroxymethyl neurosedyn derivatives as well as preparation and application thereof
03/14/2012CN102370985A Purpose of agonist of natriuretic peptide receptor A in pain management
03/14/2012CN102370984A Inhalation medicinal composition prepared from eplerenone and glucocorticoid serving as active ingredients
03/14/2012CN102370983A Anti-tumor medicine composition and purpose thereof
03/14/2012CN102370982A Haizhen nutritive refreshing medicine
03/14/2012CN102370981A Reagent and method for preventing and treating neurodegenerative diseases
03/14/2012CN102370967A Novel application of IL-1Ra (interleukin-1 receptor antagonist) and tumor treatment medicinal composition kit thereof
03/14/2012CN102370763A Application of Chinese medicinal herb immature bitter orange extract to preparation of weight-reducing and lipid-lowering medicament or preparation of medicament having lipase activity suppressing effect
03/14/2012CN102370708A Application of extracts of Chinese herbal medicine mulberry leaf in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity
03/14/2012CN102370694A Application of Chinese herbal medicine shrubby sophora extract to preparation of weight losing and lipid lowering medicament or medicament with lipase activity suppression effect
03/14/2012CN102370689A Application of extracts of Chinese herbal medicine folium sennae in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity
03/14/2012CN102370681A Application of extracts of Chinese herbal medicine rhizoma ligustici wallichii in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity
03/14/2012CN102370676A Application of extracts of Chinese herbal medicine fructus chebulae in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity
03/14/2012CN102370631A Cutaneous external patch for treating dysmenorrhea
03/14/2012CN102370619A Fat-emulsion-emulsified local anesthetic
03/13/2012US8133992 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
03/13/2012US8133918 Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
03/13/2012US8133890 Glaucoma and/or ocular hypertension; stability; lower dosage
03/13/2012US8133681 Chemo-immunotherapy method
03/13/2012US8133493 Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
03/13/2012CA2586871C Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
03/13/2012CA2586056C Aryloxy-substituted benzimidazole derivative
03/13/2012CA2530772C Composition and method for the treatment of water related ear disorders
03/13/2012CA2525615C Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine
03/13/2012CA2513144C Phospholipid derivative and method for producing the same
03/13/2012CA2503810C Therapeutic agent for fibromyalgia
03/13/2012CA2500236C Diagnosis of anorexia nervosa and bulimia nervosa using bdnf as a biological marker
03/13/2012CA2486539C C-aryl glucoside sglt2 inhibitors and method
03/13/2012CA2480468C Fredericamycin derivatives
03/13/2012CA2467159C Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
03/13/2012CA2463358C Prolonged release biodegradable microspheres and method for preparing same
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/13/2012CA2407238C The use of thymosin alpha 1 to reduce the side effects of chemotherapy in cancer patients
03/13/2012CA2402191C Use of insulin for the treatment of cartilagenous disorders
03/13/2012CA2365898C Ibd-associated microbial antigens and methods of using same
03/13/2012CA2356779C Cytokine receptor chain
03/13/2012CA2326959C Treatments for spinal muscular atrophy
03/08/2012WO2012030886A1 Combination of hdac inhibitors with thrombocytopenia drugs
03/08/2012WO2012029994A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
03/08/2012WO2012029792A1 Compound having activity for inhibiting tgf-β receptor activation, method for screening same, and composition for prevention or treatment of hepatitis c virus-induced diseases
03/08/2012WO2012029655A1 Agent for controlling hemodialysis-induced cramps
03/08/2012WO2012029415A1 Blood insulin resistance and diabetes marker progranulin, method for analyzing concentration of progranulin in blood sample, and method for screening for substance that improves insulin resistance and improves or suppresses diabetes
03/08/2012WO2012028543A1 Composition comprising a combination of dha and epa for administration prior to commencement of chemotherapy
03/08/2012WO2003032894A3 Method of monitoring neuroprotective treatment
03/08/2012US20120059462 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
03/08/2012US20120059151 Non-Functional P2X7 Receptor
03/08/2012US20120059049 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
03/08/2012US20120059031 Combinations comprising antimuscarinic agents and pde4 inhibitors
03/08/2012US20120058979 Methods and reagents for the treatment of immunoinflammatory disorders
03/08/2012US20120058958 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
1 ... 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 ... 1151